Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; The patient received her first Moderna Covid-19 bivalent vaccine booster dose on 15-Jun-2023 lot number is 023H22A expiration date is 05-Jun-2023/42-year-old patient received expired Bivalent dose of Moderna COVID-19 vaccine on 16-Jun-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received her first Moderna Covid-19 bivalent vaccine booster dose on 15-Jun-2023 lot number is 023H22A expiration date is 05-Jun-2023/42-year-old patient received expired Bivalent dose of Moderna COVID-19 vaccine on 16-Jun-2023) and NO ADVERSE EVENT (No adverse event) in a 42-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Primary series). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE.    On 16-Jun-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 16-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received her first Moderna Covid-19 bivalent vaccine booster dose on 15-Jun-2023 lot number is 023H22A expiration date is 05-Jun-2023/42-year-old patient received expired Bivalent dose of Moderna COVID-19 vaccine on 16-Jun-2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received her first Moderna Covid-19 bivalent vaccine booster dose on 15-Jun-2023 lot number is 023H22A expiration date is 05-Jun-2023/42-year-old patient received expired Bivalent dose of Moderna COVID-19 vaccine on 16-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (The patient received her first Moderna Covid-19 bivalent vaccine booster dose on 15-Jun-2023 lot number is 023H22A expiration date is 05-Jun-2023/42-year-old patient received expired Bivalent dose of Moderna COVID-19 vaccine on 16-Jun-2023).    No concomitant medications were reported.  It was reported that the vails were in intact cartons. The vial size was 2.5 ml. It was reported that the vial was initially stored in the refrigerator on 16-Jun-2023. The vial did not undergo any temperature excursions.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jun-2023: Live Significant follow-up appended: Suspect product details updated, event details updated and narrative updated.